SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
35 hedge funds and large institutions have $22.5M invested in scPharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 14
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$150K | |
| 2 | +$71K | |
| 3 | +$51K | |
| 4 |
SG Americas Securities
New York
|
+$51K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$19K |
Top Sellers
| 1 | -$666K | |
| 2 | -$502K | |
| 3 | -$131K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$67K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$64.4K |